Eli Lilly’s Retatrutide Advances in Obesity Treatment Trials: What This Means for Patients and Investors
Eli Lilly’s next-gen weight loss drug, retatrutide, has passed a key obesity trial, paving the way for potential market approval.
Eli Lilly’s next-gen weight loss drug, retatrutide, has passed a key obesity trial, paving the way for potential market approval.
A new tracker reveals family offices are increasingly investing in public stocks while reducing their real estate portfolios.
Stellantis announces a strategic five-year plan worth $70 billion, targeting positive cash flow by 2027 amid evolving market conditions.
Non-carbonated alcoholic beverages like Surfside and BeatBox are increasingly popular among Gen Z, overshadowing hard seltzers.
As consumers face rising costs, their spending on live music and concerts becomes more intentional this summer. Explore the dynamics at play.
Memorial Day weekend marks the beginning of summer travel, revealing consumer willingness to fly amidst rising fuel costs and airline struggles.
Walmart’s new CEO John Furner sees the departure of two top executives, Tom Ward and Cedric Clark, signaling a shift in leadership strategy.
LIV Golf aims to secure up to $350 million from investors as it embarks on a new phase post-PIF involvement.
IMAX has initiated preliminary discussions with potential buyers, signaling possible changes in ownership. Insights into what this could mean for the company.
Wall Street analysts reveal that IMAX has engaged in preliminary talks regarding a potential sale, raising interest among investors.
Copyright © 2026 | Celloraa Editorial Team | Editorial Policy | Privacy Policy | Disclaimer